Upload File

Download - Nonprescription Drugs Advisory Committee October 20, 2005

Transcript
Page 1: Nonprescription Drugs Advisory Committee October 20, 2005

Nonprescription Drugs Advisory CommitteeOctober 20, 2005

Open Public Hearing Speakers

Page 2: Nonprescription Drugs Advisory Committee October 20, 2005

Donald A. Goldman, M.D.

Page 3: Nonprescription Drugs Advisory Committee October 20, 2005

Sally Bloomfield, BPharm, PhDChairman and Scientific Advisory

Board Member, IFH Hon. Professor, London School of Hygiene and Tropical Medicine

Page 4: Nonprescription Drugs Advisory Committee October 20, 2005

Lawton Seal, PhDSr. Program Manager

Healthpoint R&D

Page 5: Nonprescription Drugs Advisory Committee October 20, 2005

Charles N. HaasDrexel University

Page 6: Nonprescription Drugs Advisory Committee October 20, 2005

Tammy LundstromTammy Lundstrom

Page 7: Nonprescription Drugs Advisory Committee October 20, 2005

Howard BochnekHoward Bochnek

Page 8: Nonprescription Drugs Advisory Committee October 20, 2005

Eugene C. Cole, DrPHEugene C. Cole, DrPHBrigham Young UniversityBrigham Young University

Provo, UtahProvo, Utah


Top Related

The Advertising of Prescription and Nonprescription Drugs in Magazines
The Advertising of Prescription and Nonprescription Drugs in Magazines
Dermatologic and Ophthalmic Drugs Advisory Committee
Dermatologic and Ophthalmic Drugs Advisory Committee
Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care (16th Edition)
Handbook of Nonprescription Drugs: An Interactive Approach to Self-Care (16th Edition)
Nonprescription Drugs AC Meeting October 20, 2005 1 THE QUEST FOR CLINICAL BENEFIT Steven Osborne, M.D. Medical Officer Office of Nonprescription Drug
Nonprescription Drugs AC Meeting October 20, 2005 1 THE QUEST FOR CLINICAL BENEFIT Steven Osborne, M.D. Medical Officer Office of Nonprescription Drug
Gastrointestinal Drugs Advisory Committee€¦ · Gastrointestinal Drugs Advisory Committee Introductory Remarks NDA203214 Tofacitinib: treatment of adults with moderate to severely
Gastrointestinal Drugs Advisory Committee€¦ · Gastrointestinal Drugs Advisory Committee Introductory Remarks NDA203214 Tofacitinib: treatment of adults with moderate to severely
Excluded drug list - Kaiser Permanente · o Drugs used in the treatment of weight management* Medical supplies such as dressings and antiseptics Nonprescription drugs, unless otherwise
Excluded drug list - Kaiser Permanente · o Drugs used in the treatment of weight management* Medical supplies such as dressings and antiseptics Nonprescription drugs, unless otherwise
Food and Drug Administration Modernization Act ... - gpo.gov · Noninvasive blood glucose meter. ... National uniformity for nonprescription drugs and cosmetics. ... by striking ‘‘Service
Food and Drug Administration Modernization Act ... - gpo.gov · Noninvasive blood glucose meter. ... National uniformity for nonprescription drugs and cosmetics. ... by striking ‘‘Service
Label Comprehension, Self-Selection & Actual Use Studies: Issues & Challenges Nonprescription Drugs Advisory Committee September 25, 2006 Andrea Leonard-Segal,
Label Comprehension, Self-Selection & Actual Use Studies: Issues & Challenges Nonprescription Drugs Advisory Committee September 25, 2006 Andrea Leonard-Segal,